These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 24585944)
1. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma. Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944 [TBL] [Abstract][Full Text] [Related]
2. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography. Tsuchida T; Morikawa M; Demura Y; Umeda Y; Okazawa H; Kimura H J Magn Reson Imaging; 2013 Jul; 38(1):80-8. PubMed ID: 23239463 [TBL] [Abstract][Full Text] [Related]
3. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT. Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444 [TBL] [Abstract][Full Text] [Related]
5. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320 [TBL] [Abstract][Full Text] [Related]
7. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes. Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992 [TBL] [Abstract][Full Text] [Related]
8. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [TBL] [Abstract][Full Text] [Related]
10. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]. Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820 [TBL] [Abstract][Full Text] [Related]
11. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
12. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921 [TBL] [Abstract][Full Text] [Related]
13. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Qiu L; Chen Y; Wu J Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment. Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734 [TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209 [TBL] [Abstract][Full Text] [Related]
16. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
17. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511 [TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549 [TBL] [Abstract][Full Text] [Related]
19. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD. Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392 [TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]